Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Sinbobon Sep 18, 2012 8:03pm
206 Views
Post# 20382515

Actually....

Actually....

if one is a 'techie' , you could look at the chart two ways. We had a run from $1.20 to $2...so a pullback to the halfway point, which is very common, would bring the price back to about $1.60. However, if we look at the little blip pullback at $1.60 and the run too $2...the pullback is right around $1.80...about where we are now...a very healthy process.

 

Also, even if you know nothing about the technology you have to know that the stock is very tightly held with over 51% insiders holding stock plus many long term investors holding a lot of shares close to their vest. This leaves a small float for traders and no-gooders to play with. To short this stock woild be risky...to naked short it would be very, very risky because it is easily traceable due to the low float and the overall low shares outstanding, much harder to do. I suspect the trading is being influenced somehow to keep things low key. Just my opinion others will disagree with.

There will be much good news coming in some succession. If it is big news, the stock will act accordingly. Little news, little pay...big news, big pay. Gawd I wish I could be a fly on the wall at Bioasis.

 

 

Bullboard Posts